U.S. stocks fell for a second day as an early rally sparked by better-than-forecast economic growth faded before a Federal Reserve decision on monetary policy.

Genworth Financial Inc. lost 10 percent as higher-than-estimated claims costs at its long-term care insurance unit prompted a company review of whether its reserves are adequate. Twitter Inc. (TWTR:US) soared 21 percent as results beat estimates and the company boosted its annual sales projection. Amgen Inc. (AMGN:US) and Regeneron Pharmaceuticals Inc. led a rally in biotechnology shares.

The Standard & Poor’s 500 Index (SPX) fell 0.2 percent to 1,966.43 at 11:12 a.m. in New York, after rising as much as 0.5 percent earlier. The Dow Jones Industrial Average lost 67.16 points, or 0.4 percent, to 16,844.95. The Nasdaq 100 Index increased 0.2 percent.

Read more

Related Articles